MedPath

Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders

Not Applicable
Completed
Conditions
Alcohol Dependence
Registration Number
NCT02968537
Lead Sponsor
University of Bern
Brief Summary

The study aims to investigate the effects of a short computerized training as a therapeutic add-on to standard therapy in patients with alcohol-use disorder.

Detailed Description

Therapeutic interventions to treat alcohol use disorders (AUD) still need to be improved. A novel alcohol-specific inhibition-training seems to be a promising new intervention. In this study, recently abstinent patients with AUD attending an inpatient treatment program will be randomly assigned to one of two alcohol-specific inhibition-training groups (varying in Go/NoGo-ratio) or to a control condition. Besides the effects on drinking behavior, inhibition and implicit attitudes, the investigators expect the training to influence neurophysiological reactivity to alcohol related stimuli. A subgroup of patients will therefore additionally undergo EEG recording so that the neurophysiological effects of the training can be assessed and related to clinical outcome. Furthermore, since training effects rely on learning processes, the influence of endogenous cortisol level (a consolidation-enhancer which peaks in the morning) on training outcome will be examined by the variation of daytime of the training. All patients' inhibitory control and implicit associations towards alcohol will be measured before and after training. The training effects will be examined on proximal outcome variables (e.g. implicit associations, inhibitory control, abstinence related self-efficacy, craving) and on distal outcome variables at 3-, 6- and 12- months follow-up (e.g. percent abstinent days (primary outcome)).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
242
Inclusion Criteria
  • Abstinent patients with an alcohol use disorder in the 12-week inpatient program of the Clinic Südhang or the Forel Clinic,
  • Abstained from alcohol for at least 4 weeks (in relation to timepoint when training will start),
  • Informed Consent as documented by signature.
Exclusion Criteria
  • Other main psychiatric diagnosis than alcohol use disorder (comorbidity is allowed if the alcohol use disorder is to be considered the main diagnosis),
  • other severe substance use disorder (except nicotine), even as secondary diagnosis
  • Neurocognitive problems (e.g. Korsakoff syndrome),
  • Current medical conditions excluding participation (e.g. acute infectious disease),
  • Inability to read and understand the participant's information,
  • Enrolment of the investigator, his/her family members, employees and other dependent persons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percent days of abstinence 3-months follow-up.3-months follow-up

Percentage of abstinent days in 3-months follow-up. This will be measured with the timeline follow back (TFB), which is a validated procedure to aid recall of past drinking and evaluates information about drinking behavior.

Inhibition Go/NoGoPost training, i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session

Inhibitory control as assessed with a Go/NoGo task.

Implicit associations (IAT)Post training, i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session

Implicit associations as assessed with an alcohol-related implicit association task (IAT)

Heavy drinking days in 3 months follow-up3 months follow-up

in 3-months follow-up. This will be measured Heavy drinking days in 3 months follow-up, measured with the timeline follow back (TFB), which is a validated procedure to aid recall of past drinking and evaluates information about drinking behavior.

Neurophysiology of inhibitory Control (Go/NoGo)Post training, i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session

Neurophysiological correlates of inhibitory control as assessed with EEG-measurement during the Go-NOGo-task. ERPs in response to NoGo-Stimuli will be calculated and the N2/p3-complex will be analyzed

Secondary Outcome Measures
NameTimeMethod
CravingPost-training (i.e. between 1 and 7 days after completion of the last training session); discharge, 3-, 6- and 12-months follow-up

Craving will be measured with the German version of the Obsessive compulsive drinking scale (OCDS-G).

Abstinence related self-efficacyPost-training (i.e. between 1 and 7 days after completion of the training session); discharge, 3-, 6- and 12-months follow-up

Self efficacy will be assessed with the alcohol abstinence self-efficacy scale (AASE).

Inhibition (SST)Post-training; i.e. between 1 and 7 days after completion of the last (i.e. the 6th) training session

Inhibitory control will be assessed with a Stop-Signal task

Percent heavy drinking days3-, 6- and 12-months follow-up
Time to first drink3-, 6- and 12-months follow-up

Trial Locations

Locations (3)

Forel Klinik

🇨🇭

Ellikon, Switzerland

Klinik Südhang

🇨🇭

Kirchlindach, Switzerland

Psychiatric Center Muensingen

🇨🇭

Münsingen, Switzerland

Forel Klinik
🇨🇭Ellikon, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.